Timothy P. Moran

Insider · Director · ADGM

Timothy P. Moran files insider transactions with the SEC as a chief business officer of Kestra Medical Technologies (KMTS). We hold 3 disclosed purchases and sales filed since 9 November 2018, 3 of them in the last 90 days.

Files forADGM
Disclosed buys and sells3 in all, 3 in the last 90 days
Last disclosure3 August 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed

Filed 3 December 2025 — 3 August 2026Chief Business Officer · Kestra Medical Technologies (KMTS)7 Form 4 lines · source: SEC Form 4
Filed 20 March 2025 — 16 June 2026Director · Adagio Medical Holdings (ADGM)2 Form 4 lines · source: SEC Form 4
Filed 8 November 2018 — 5 March 2024Chief Executive Officer · Motus GI Holdings (MOTS)19 Form 4 lines · source: SEC Form 4

Everything they disclosed

28 entries, newest first — one per disclosure report, one per Form 4 line

was granted 30,000 shares of Adagio Medical Holdings (a derivative holding)SEC Form 412 August 2026Non-qualified stock option (right to buy) · traded 16 June 2026 · filed 12 August 2026
▼ sold on the open market 4,117 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 30 July 2026 · filed 3 August 2026
▼ sold on the open market 8,759 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 31 July 2026 · filed 3 August 2026
▼ sold on the open market 2,380 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 3 August 2026 · filed 3 August 2026
was granted 39,113 shares of Kestra Medical TechnologiesSEC Form 417 July 2026Common Shares · traded 16 July 2026 · filed 17 July 2026
was granted 227 shares of Kestra Medical TechnologiesSEC Form 42 July 2026Common Stock · traded 30 June 2026 · filed 2 July 2026
was granted 22,704 shares of Kestra Medical TechnologiesSEC Form 44 June 2026Common Shares · traded 3 June 2026 · filed 4 June 2026
was granted 19,557 shares of Kestra Medical TechnologiesSEC Form 44 December 2025Common Shares · traded 3 December 2025 · filed 4 December 2025
was granted 90,000 shares of Adagio Medical Holdings (a derivative holding)SEC Form 421 March 2025Non-qualified stock option (right to buy) · traded 20 March 2025 · filed 21 March 2025
was granted 23,205 shares of Motus GI Holdings (a derivative holding)SEC Form 412 March 2024Stock Option (right to buy) · traded 5 March 2024 · filed 12 March 2024
was granted 175,000 shares of Motus GI Holdings (a derivative holding)SEC Form 411 February 2022Stock Option (right to buy) · traded 10 February 2022 · filed 11 February 2022
was granted 175,000 shares of Motus GI HoldingsSEC Form 411 February 2022Common Stock, par value $0.0001 per share · traded 10 February 2022 · filed 11 February 2022
▲ bought on the open market 10,000 shares of Motus GI HoldingsSEC Form 422 November 2021Common Stock, par value $0.0001 per share · traded 19 November 2021 · filed 22 November 2021
was granted 141,000 shares of Motus GI HoldingsSEC Form 419 February 2021Common Stock, par value $0.0001 per share · traded 17 February 2021 · filed 19 February 2021
was granted 141,000 shares of Motus GI Holdings (a derivative holding)SEC Form 419 February 2021Stock Option (right to buy) · traded 17 February 2021 · filed 19 February 2021
▲ bought on the open market 10,000 shares of Motus GI HoldingsSEC Form 47 December 2020Common Stock, par value $0.0001 per share · traded 4 December 2020 · filed 7 December 2020
was granted 190,000 shares of Motus GI Holdings (a derivative holding)SEC Form 413 November 2020Stock Option (right to buy) · traded 11 November 2020 · filed 13 November 2020
was granted 200,000 shares of Motus GI Holdings (a derivative holding)SEC Form 412 June 2020Stock Option (right to buy) · traded 11 June 2020 · filed 12 June 2020
was granted 103,720 shares of Motus GI Holdings (a derivative holding)SEC Form 47 February 2020Stock Option (right to buy) · traded 6 February 2020 · filed 7 February 2020
was granted 103,720 shares of Motus GI HoldingsSEC Form 47 February 2020Common Stock, par value $0.0001 per share · traded 6 February 2020 · filed 7 February 2020
▲ bought on the open market 10,000 shares of Motus GI HoldingsSEC Form 420 November 2019Common Stock, par value $0.0001 per share · traded 20 November 2019 · filed 20 November 2019
▲ bought on the open market 3,333 shares of Motus GI HoldingsSEC Form 41 July 2019Common Stock, par value $0.0001 per share · traded 1 July 2019 · filed 1 July 2019
▲ bought on the open market 5,000 shares of Motus GI HoldingsSEC Form 424 May 2019Common Stock, par value $0.0001 per share · traded 22 May 2019 · filed 24 May 2019
was granted 28,944 shares of Motus GI Holdings (a derivative holding)SEC Form 415 February 2019Stock Option (right to buy) · traded 13 February 2019 · filed 15 February 2019
was granted 174,648 shares of Motus GI HoldingsSEC Form 415 February 2019Common Stock, par value $0.0001 per share · traded 13 February 2019 · filed 15 February 2019
▲ bought on the open market 10,000 shares of Motus GI HoldingsSEC Form 426 December 2018Common Stock, par value $0.0001 per share · traded 24 December 2018 · filed 26 December 2018
▲ bought on the open market 15,000 shares of Motus GI HoldingsSEC Form 421 November 2018Common Stock, par value $0.0001 per share · traded 19 November 2018 · filed 21 November 2018
was granted 495,000 shares of Motus GI Holdings (a derivative holding)SEC Form 49 November 2018Stock Option (right to buy) · traded 8 November 2018 · filed 9 November 2018

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.